STOCK TITAN
  1. Home
  2. Sec-filings
  3. GKOS
  4. [Form 4] GLAUKOS Corp Insider Trading Activity

Glaukos Corp (NYSE: GKOS) director Wen sells 525 shares

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Glaukos Corp director Leana Wen sold 525 shares of common stock on July 31, 2026 at $167.63 per share in a sale described as an open-market or private transaction. After the sale, she reports holding 21,092 shares, including 2,501 restricted stock units that are unvested or with deferred delivery. The transaction was not reported as made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider WEN LEANA
Role Director
Sold 525 shs ($88K)
Type Security Shares Price Value
Sale Common Stock F1 525 $167.63 $88K
Holdings After Transaction: Common Stock — 21,092 shares (Direct)
Footnotes (1)
  1. F1. Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
Shares sold 525.0000 shares Common stock sold on July 31, 2026 in a non-derivative transaction
Sale price $167.6300 per share Per-share price for the July 31, 2026 common stock sale
Post-transaction holdings 21092.0000 shares Total common shares reported as beneficially owned after the sale
Restricted stock units 2,501 restricted stock units RSUs included within the reported post-transaction holdings
restricted stock units financial
"Includes 2,501 restricted stock units that have not vested or been delivered"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open market or private transaction financial
"Transaction code description: Sale in open market or private transaction"
Reporting Person regulatory
"delivery of which has been deferred by the Reporting Person"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did director Leana Wen report for Glaukos (GKOS)?
Director Leana Wen reported selling 525 shares of Glaukos common stock on July 31, 2026. The sale was recorded as a sale in open market or private transaction, reducing but not eliminating her equity position in the company.

How many Glaukos (GKOS) shares did Leana Wen sell and at what price?
Leana Wen sold 525 Glaukos common shares at $167.63 per share. This single transaction involved non-derivative common stock and was reported as a standard open-market or private sale, based on the Form 4 transaction code description.

How many Glaukos (GKOS) shares does Leana Wen hold after this Form 4 sale?
Following the reported sale, Leana Wen holds 21,092 Glaukos common shares. This reported figure includes both regular common shares and certain restricted stock units that are either unvested or vested with deferred delivery.

Does Leana Wen’s Glaukos (GKOS) position include restricted stock units?
Yes. Her reported post-transaction holdings of 21,092 shares include 2,501 restricted stock units. These RSUs have not yet vested or been delivered, or have vested but their delivery has been deferred at her election.

Was Leana Wen’s July 31, 2026 Glaukos (GKOS) sale under a Rule 10b5-1 plan?
The sale was not reported as being made under a Rule 10b5-1 trading plan. The Form 4 indicates the Rule 10b5-1 checkbox was not marked, suggesting the transaction was not executed pursuant to a pre-arranged trading plan.

What type of transaction code is used for Leana Wen’s Glaukos (GKOS) sale?
The filing uses transaction code S, described as a sale in open market or private transaction. This code indicates a straightforward disposition of common stock rather than an option exercise, tax withholding, gift, or other non-standard equity event.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEN LEANA
(Last)(First)(Middle)
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY
(Street)
ALISO VIEJO CALIFORNIA 92656
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026S525D$167.6321,092(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
/s/ Diana Scherer, Attorney-in-Fact08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR